- Home
- TNGX vs YSG Comparison
TNGX vs YSG Comparison
Compare TNGX & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- YSG
- Stock Information
- Founded
- TNGX 2014
- YSG 2016
- Country
- TNGX United States
- YSG China
- Employees
- TNGX N/A
- YSG N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- YSG Package Goods/Cosmetics
- Sector
- TNGX Health Care
- YSG Consumer Discretionary
- Exchange
- TNGX Nasdaq
- YSG Nasdaq
- Market Cap
- TNGX 1.0B
- YSG 889.0M
- IPO Year
- TNGX N/A
- YSG 2020
- Fundamental
- Price
- TNGX $7.99
- YSG $6.50
- Analyst Decision
- TNGX Strong Buy
- YSG
- Analyst Count
- TNGX 6
- YSG 0
- Target Price
- TNGX $10.80
- YSG N/A
- AVG Volume (30 Days)
- TNGX 4.3M
- YSG 230.9K
- Earning Date
- TNGX 11-04-2025
- YSG 11-20-2025
- Dividend Yield
- TNGX N/A
- YSG N/A
- EPS Growth
- TNGX N/A
- YSG N/A
- EPS
- TNGX N/A
- YSG N/A
- Revenue
- TNGX $66,501,000.00
- YSG $522,879,337.00
- Revenue This Year
- TNGX $20.41
- YSG $24.18
- Revenue Next Year
- TNGX N/A
- YSG $14.76
- P/E Ratio
- TNGX N/A
- YSG N/A
- Revenue Growth
- TNGX 53.29
- YSG 11.53
- 52 Week Low
- TNGX $1.03
- YSG $3.01
- 52 Week High
- TNGX $9.70
- YSG $11.57
- Technical
- Relative Strength Index (RSI)
- TNGX 49.39
- YSG 33.12
- Support Level
- TNGX $7.12
- YSG $6.33
- Resistance Level
- TNGX $8.17
- YSG $6.98
- Average True Range (ATR)
- TNGX 0.74
- YSG 0.41
- MACD
- TNGX -0.07
- YSG -0.07
- Stochastic Oscillator
- TNGX 45.74
- YSG 6.21
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.